Osteoporosis management
Healing Pharma’s Risedronate (often branded as part of their bone health portfolio) is a bisphosphonate medication, typically available in 35 mg (weekly) or 150 mg (monthly) strengths, designed to treat postmenopausal and male osteoporosis by strengthening bones, increasing density, and reducing fracture risks. It works by inhibiting osteoclasts to reduce bone resorption.
